Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ratcliffe

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Molecular Oral Microbiology|October 18, 2023
Metabolism of serine/glycine lipids by human gingival cells in cultureTyler M Guido, Samuel D Ratcliffe, Amanda Rahmlow, et al.
Gut|December 22, 1999
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipientD Mutimer, D Pillay, P Shields, et al.
International Journal of STD & AIDS|August 12, 2016
Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog StudyT J Barber, L Bansi, A Pozniak, et al.
Nanoscale|July 14, 2016
Bespoke contrast-matched diblock copolymer nanoparticles enable the rational design of highly transparent Pickering double emulsionsMatthew J Rymaruk, Kate L Thompson, Matthew J Derry, et al.
Macromolecules|November 20, 2018
Critical Dependence of Molecular Weight on Thermoresponsive Behavior of Diblock Copolymer Worm Gels in Aqueous SolutionNicholas J Warren, Matthew J Derry, Oleksandr O Mykhaylyk, et al.
Soft Matter|January 26, 2017
Synthesis of polyacid nanogels: pH-responsive sub-100 nm particles for functionalisation and fluorescent hydrogel assemblyAmir H Milani, Jennifer M Saunders, Nam T Nguyen, et al.
AIDS Care|July 23, 2013
Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunitiesT J Barber, D Bradshaw, D Hughes, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41L Xu, A Pozniak, A Wildfire, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Rapid access towards follow-up NOP receptor agonists using a knowledge based approachRonald Palin, John K Clark, Louise Evans, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptorAngus J Morrison, Julia M Adam, James A Baker, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Molecular Oral Microbiology|October 18, 2023
Metabolism of serine/glycine lipids by human gingival cells in cultureTyler M Guido, Samuel D Ratcliffe, Amanda Rahmlow, et al.
Gut|December 22, 1999
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipientD Mutimer, D Pillay, P Shields, et al.
International Journal of STD & AIDS|August 12, 2016
Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog StudyT J Barber, L Bansi, A Pozniak, et al.
Nanoscale|July 14, 2016
Bespoke contrast-matched diblock copolymer nanoparticles enable the rational design of highly transparent Pickering double emulsionsMatthew J Rymaruk, Kate L Thompson, Matthew J Derry, et al.
Macromolecules|November 20, 2018
Critical Dependence of Molecular Weight on Thermoresponsive Behavior of Diblock Copolymer Worm Gels in Aqueous SolutionNicholas J Warren, Matthew J Derry, Oleksandr O Mykhaylyk, et al.
Soft Matter|January 26, 2017
Synthesis of polyacid nanogels: pH-responsive sub-100 nm particles for functionalisation and fluorescent hydrogel assemblyAmir H Milani, Jennifer M Saunders, Nam T Nguyen, et al.
AIDS Care|July 23, 2013
Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunitiesT J Barber, D Bradshaw, D Hughes, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41L Xu, A Pozniak, A Wildfire, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Rapid access towards follow-up NOP receptor agonists using a knowledge based approachRonald Palin, John K Clark, Louise Evans, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptorAngus J Morrison, Julia M Adam, James A Baker, et al.
Pageof 6